PURE Bioscience, Inc. (OTCMKTS:PURE) Sees Significant Increase in Short Interest

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 4,400 shares, an increase of 1,000.0% from the December 31st total of 400 shares. Based on an average daily trading volume, of 233,200 shares, the short-interest ratio is currently 0.0 days.

PURE Bioscience Trading Up 5.3 %

OTCMKTS:PURE traded up $0.00 during trading hours on Wednesday, reaching $0.07. 100,915 shares of the company traded hands, compared to its average volume of 78,395. PURE Bioscience has a 1 year low of $0.06 and a 1 year high of $0.16. The stock has a market capitalization of $8.21 million, a P/E ratio of -1.84 and a beta of 0.07. The business’s 50-day moving average price is $0.07 and its two-hundred day moving average price is $0.08.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings results on Monday, December 16th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.